ArticleMolecular oncology2016

Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy.

Frieder Bauss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.